Daidzein, its effects on impaired glucose and lipid metabolism and vascular inflammation associated with type 2 diabetes

BioFactors

Volumn 44, Issue 5, 2018, Pages 407-417

  Das, Dibyendu ^a,b   Sarkar, Sanjib ^a,b   Bordoloi, Jijnasa ^a,b   Wann, Sawlang Borsingh ^a,b   Kalita, Jatin ^a,b   Manna, Prasenjit ^a,b  

^a CSIR NORTH EAST INSTITUTE OF SCIENCE AND TECHNOLOGY   (India)

^b ACADEMY OF SCIENTIFIC AND INNOVATIVE RESEARCH ACSIR   (India)

Author keywords

adjuvant therapeutic; daidzein; impaired glucose and lipid metabolism; type 2 diabetes; vascular inflammation

Indexed keywords

DAIDZEIN; GLUCOSE; LIPID; ANTIDIABETIC AGENT; ISOFLAVONE DERIVATIVE;

ANTIDIABETIC ACTIVITY; BIOCHEMISTRY; CLINICAL TRIAL (TOPIC); DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; GLUCOSE METABOLISM; HUMAN; LIPID METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; VASCULITIS; CHEMISTRY; INFLAMMATION; INSULIN RESISTANCE; METABOLISM; PATHOLOGY; SOYBEAN;

DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; INSULIN RESISTANCE; ISOFLAVONES; LIPID METABOLISM; SOYBEANS;

EID: 85052910881     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1439     Document Type: Review

References (75)

1. Messina, M., Nagata, C., and Wu, A. H. (2006) Estimated Asian adult soy protein and isoflavone intakes. Nutr. Cancer. 55, 1–12
2. Zamora-Ros, R., Jimenez, C., Cleries, R., Agudo, A., Sanchez, M. J., et al. (2013) Dietary flavonoid and lignan intake and mortality in a Spanish cohort. Epidemiology. 24, 726–733
3. van der Schouw, Y. T., Kreijkamp-Kaspers, S., Peeters, P. H., Keinan-Boker, L., Rimm, E. B., et al. (2005) Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in Western women. Circulation. 111, 465–471
4. Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L., Hong, C. P., et al. (2007) Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 85, 895–909
5. Kurzer, M. S., and Xu, X. (1997) Dietary phytoestrogens. Dietary phytoestrogens. Annu. Rev. Nutr. 17, 353–381
6. Dixon, R. A. (2004) Phytoestrogens. Phytoestrogens. Annu. Rev. Plant Biol. 55, 225–261
7. Kwon, D. Y., Daily, J. W., 3rd, Kim, H. J., and Park, S. (2010) Antidiabetic effects of fermented soybean products on type 2 diabetes. Nutr. Res. 30, 1–13
8. Rowland, I. R., Wiseman, H., Sanders, T. A., Adlercreutz, H., and Bowey, E. A. (2000) Interindividual variation in metabolism of soy isoflavones and lignans: influence of habitual diet on equol production by the gut microflora. Nutr. Cancer. 36, 27–32
9. Cho, K. W., Lee, O. H., Banz, W. J., Moustaid-Moussa, N., Shay, N. F., et al. (2010) Daidzein and the daidzein metabolite, equol, enhance adipocyte differentiation and PPARgamma transcriptional activity. J. Nutr. Biochem. 21, 841–847
10. Cheong, S. H., Furuhashi, K., Ito, K., Nagaoka, M., Yonezawa, T., et al. (2014) Antihyperglycemic effect of equol, a daidzein derivative, in cultured L6 myocytes and ob/ob mice. Mol. Nutr. Food Res. 58, 267–277
11. Jung, W., Yu, O., Lau, S. M., O'Keefe, D. P., Odell, J., et al. (2000) Identification and expression of isoflavone synthase, the key enzyme for biosynthesis of isoflavones in legumes. Nat. Biotechnol. 18, 208–212
12. Ahmed, T., Javed, S., Tariq, A., Budzynska, B., D'Onofrio, G., et al. (2017) Daidzein and its effects on brain. Curr. Med. Chem. 24, 365–375
13. Murphy, P. A., Song, T., Buseman, G., Barua, K., Beecher, G. R., et al. (1999) Isoflavones in retail and institutional soy foods. J. Agric. Food Chem. 47, 2697–2704
14. Barnes, S., Kirk, M., and Coward, L. (1994) Isoflavones and their conjugates in soy foods: extraction conditions and analysis by HPLC-mass spectrometry. J. Agric. Food Chem. 42, 2466–2474
15. Shelnutt, S. R., Cimino, C. O., Wiggins, P. A., Ronis, M. J., and Badger, T. M. (2002) Pharmacokinetics of the glucuronide and sulfate conjugates of genistein and daidzein in men and women after consumption of a soy beverage. Am. J. Clin. Nutr. 76, 588–594
16. Bhathena, S. J., and Velasquez, M. T. (2002) Beneficial role of dietary phytoestrogens in obesity and diabetes. Am. J. Clin. Nutr. 76, 1191–1201
17. USDA. (2007) USDA-Iowa State University database on the isoflavone content of foods. U.S. Department of Agriculture, Agricultural Research Service, Beltsville Human Nutrition Research Center, Nutrient Data Laboratory, Beltsville, MD
18. Velasquez, M. T., and Bhathena, S. J. (2007) Role of dietary soy protein in obesity. Int. J. Med. Sci. 4, 72–82
19. Wang, H., and Murphy, P. A. (1994) Isoflavone content in commercial soybean foods. J. Agric. Food Chem. 42, 1666–1673
20. Coward, L., Barnes, N. C., Setchell, K. D. R., and Barnes, S. (1993) Genistein, daidzein, and their.beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J. Agric. Food Chem. 41, 1961–1967
21. Cheng, K.-C., Lin, J.-T., Wu, J.-Y., and Liu, W.-H. (2010) Isoflavone conversion of black soybean by immobilized Rhizopus spp. Food Biotechnol. 24, 312–331
22. Horii, K., Adachi, T., Matsuda, T., Tanaka, T., Sahara, H., et al. (2009) Improvement of isoflavone aglycones production using β-glucosidase secretory produced in recombinant Aspergillus oryzae. J. Mol. Catal. B Enzym. 59, 297–301
23. Kuo, L. C., Cheng, W. Y., Wu, R. Y., Huang, C. J., and Lee, K. T. (2006) Hydrolysis of black soybean isoflavone glycosides by Bacillus subtilis natto. Appl. Microb. Biotechnol. 73, 314–320
24. Delmonte, P., and Rader, J. I. (2006) Analysis of isoflavones in foods and dietary supplements. J AOAC Int. 89, 1138–1146
25. Jin, S. E., Son, Y. K., Min, B. S., Jung, H. A., and Choi, J. S. (2012) Anti-inflammatory and antioxidant activities of constituents isolated from Pueraria lobata roots. Arch. Pharm. Res. 35, 823–837
26. Prasain, J. K., Jones, K., Kirk, M., Wilson, L., Smith-Johnson, M., et al. (2003) Profiling and quantification of isoflavonoids in kudzu dietary supplements by high-performance liquid chromatography and electrospray ionization tandem mass spectrometry. J. Agric. Food Chem. 51, 4213–4218
27. Maji, A. K., Pandit, S., Banerji, P., and Banerjee, D. (2014) Pueraria tuberosa: a review on its phytochemical and therapeutic potential. Nat. Prod. Res. 28, 2111–2127
28. Coward, L., Smith, M., Kirk, M., and Barnes, S. (1998) Chemical modification of isoflavones in soyfoods during cooking and processing. Am. J. Clin. Nutr. 68, 1486S–1491S
29. Otieno, D. O., and Shah, N. P. (2007) Endogenous beta-glucosidase and beta-galactosidase activities from selected probiotic micro-organisms and their role in isoflavone biotransformation in soymilk. J. Appl. Microbiol. 103, 910–917
30. Day, A. J., DuPont, M. S., Ridley, S., Rhodes, M., Rhodes, M. J., et al. (1998) Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver beta-glucosidase activity. FEBS Lett. 436, 71–75
31. Raimondi, S., Roncaglia, L., De Lucia, M., Amaretti, A., Leonardi, A., et al. (2009) Bioconversion of soy isoflavones daidzin and daidzein by Bifidobacterium strains. Appl. Microbiol. Biotechnol. 81, 943–950
32. Park, H. Y., Kim, M., and Han, J. (2011) Stereospecific microbial production of isoflavanones from isoflavones and isoflavone glucosides. Appl. Microbiol. Biotechnol. 91, 1173–1181
33. Tamura, M., Tsushida, T., and Shinohara, K. (2007) Isolation of an isoflavone-metabolizing, Clostridium-like bacterium, strain TM-40, from human faeces. Anaerobe. 13, 32–35
34. Kelly, G. E., Joannou, G. E., Reeder, A. Y., Nelson, C., and Waring, M. A. (1995) The variable metabolic response to dietary isoflavones in humans. Proc. Soc. Exp. Biol. Med. 208, 40–43
35. Hur, H. G., Beger, R. D., Heinze, T. M., Lay, J. O., Jr., Freeman, J. P., et al. (2002) Isolation of an anaerobic intestinal bacterium capable of cleaving the C-ring of the isoflavonoid daidzein. Arch. Microbiol. 178, 8–12
36. Yokoyama, S., Niwa, T., Osawa, T., and Suzuki, T. (2010) Characterization of an O-desmethylangolensin-producing bacterium isolated from human feces. Arch. Microbiol. 192, 15–22
37. Schoefer, L., Mohan, R., Braune, A., Birringer, M., and Blaut, M. (2002) Anaerobic C-ring cleavage of genistein and daidzein by Eubacterium ramulus. FEMS Microbiol. Lett. 208, 197–202
38. Matthies, A., Blaut, M., and Braune, A. (2009) Isolation of a human intestinal bacterium capable of daidzein and genistein conversion. Appl. Environ. Microbiol. 75, 1740–1744
39. Tsuji, H., Moriyama, K., Nomoto, K., Miyanaga, N., and Akaza, H. (2010) Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS. Arch Microbiol. 192, 279–287
40. Matthies, A., Clavel, T., Gutschow, M., Engst, W., Haller, D., et al. (2008) Conversion of daidzein and genistein by an anaerobic bacterium newly isolated from the mouse intestine. Appl. Environ. Microbiol. 74, 4847–4852
41. Prasain, J. K., Jones, K., Brissie, N., Moore, R., Wyss, J. M., et al. (2004) Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry. J. Agric. Food Chem. 52, 3708–3712
42. Xiao, B. X., Feng, L., Cao, F. R., Pan, R. L., Liao, Y. H., et al. (2016) Pharmacokinetic profiles of the five isoflavonoids from Pueraria lobata roots in the CSF and plasma of rats. J. Ethnopharmacol. 184, 22–29
43. Zhang, Y. B., Yang, X. B., Yang, X. W., Xu, W., Li, F., et al. (2016) Liquid chromatography with tandem mass spectrometry: a sensitive method for the determination of dehydrodiisoeugenol in rat cerebral nuclei. Molecules. 21, 321
44. Halm, B. M., Ashburn, L. A., and Franke, A. A. (2007) Isoflavones from soya foods are more bioavailable in children than adults. Br. J. Nutr. 98, 998–1005
45. Franke, A. A., Halm, B. M., and Ashburn, L. A. (2008) Isoflavones in children and adults consuming soy. Arch. Biochem. Biophys. 476, 161–170
46. Cheong, S. H., Furuhashi, K., Ito, K., Nagaoka, M., Yonezawa, T., et al. (2014) Daidzein promotes glucose uptake through glucose transporter 4 translocation to plasma membrane in L6 myocytes and improves glucose homeostasis in Type 2 diabetic model mice. J. Nutr. Biochem. 25, 136–143
47. Park, M. H., Ju, J. W., Park, M. J., and Han, J. S. (2013) Daidzein inhibits carbohydrate digestive enzymes in vitro and alleviates postprandial hyperglycemia in diabetic mice. Eur. J. Pharmacol. 712, 48–52
48. Sakamoto, Y., Kanatsu, J., Toh, M., Naka, A., Kondo, K., et al. (2016) The dietary isoflavone daidzein reduces expression of pro-inflammatory genes through PPARalpha/gamma and JNK pathways in adipocyte and macrophage co-cultures. PLoS One. 11, e0149676
49. Li, H. Y., Pan, L., Ke, Y. S., Batnasan, E., Jin, X. Q., et al. (2014) Daidzein suppresses pro-inflammatory chemokine Cxcl2 transcription in TNF-alpha-stimulated murine lung epithelial cells via depressing PARP-1 activity. Acta Pharmacol. Sin. 35, 496–503
50. Choi, M. S., Jung, U. J., Yeo, J., Kim, M. J., and Lee, M. K. (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab. Res. Rev. 24, 74–81
51. Ae Park, S., Choi, M. S., Cho, S. Y., Seo, J. S., Jung, U. J., et al. (2006) Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 79, 1207–1213
52. Cao, Y. K., Zhang, S. F., Zou, S. E., and Xia, X. (2013) Daidzein improves insulin resistance in ovariectomized rats. Climacteric. 16, 111–116
53. Zang, Y., Igarashi, K., and Yu, C. (2015) Anti-obese and anti-diabetic effects of a mixture of daidzin and glycitin on C57BL/6J mice fed with a high-fat diet. Biosci. Biotechnol. Biochem. 79, 117–123
54. Meezan, E., Meezan, E. M., Jones, K., Moore, R., Barnes, S., et al. (2005) Contrasting effects of puerarin and daidzin on glucose homeostasis in mice. J. Agric. Food Chem. 53, 8760–8767
55. Usui, T., Tochiya, M., Sasaki, Y., Muranaka, K., Yamakage, H., et al. (2013) Effects of natural S-equol supplements on overweight or obesity and metabolic syndrome in the Japanese, based on sex and equol status. Clin. Endocrinol (Oxf). 78, 365–372
56. Shi, L., Ryan, H. H., Jones, E., Simas, T. A., Lichtenstein, A. H., et al. (2014) Urinary isoflavone concentrations are inversely associated with cardiometabolic risk markers in pregnant U.S. women. J. Nutr. 144, 344–351
57. Clerici, C., Nardi, E., Battezzati, P. M., Asciutti, S., Castellani, D., et al. (2011) Novel soy germ pasta improves endothelial function, blood pressure, and oxidative stress in patients with type 2 diabetes. Diabetes Care. 34, 1946–1948
58. Anderson, J. W., Blake, J. E., Turner, J., and Smith, B. M. (1998) Effects of soy protein on renal function and proteinuria in patients with type 2 diabetes. Am. J. Clin. Nutr. 68, 1347S–1353S
59. Azadbakht, L., Atabak, S., and Esmaillzadeh, A. (2008) Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial. Diabetes Care. 31, 648–654
60. Teixeira, S. R., Tappenden, K. A., Carson, L., Jones, R., Prabhudesai, M., et al. (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J. Nutr. 134, 1874–1880
61. Pipe, E. A., Gobert, C. P., Capes, S. E., Darlington, G. A., Lampe, J. W., et al. (2009) Soy protein reduces serum LDL cholesterol and the LDL cholesterol:HDL cholesterol and apolipoprotein B:apolipoprotein A-I ratios in adults with type 2 diabetes. J. Nutr. 139, 1700–1706
62. Nguyen, C. T., Pham, N. M., Do, V. V., Binns, C. W., Hoang, V. M., et al. (2017) Soyfood and isoflavone intake and risk of type 2 diabetes in Vietnamese adults. Eur. J. Clin. Nutr. 71, 1186–1192
63. Ho, S. C., Chen, Y. M., Ho, S. S., and Woo, J. L. (2007) Soy isoflavone supplementation and fasting serum glucose and lipid profile among postmenopausal Chinese women: a double-blind, randomized, placebo-controlled trial. Menopause. 14, 905–912
64. Villegas, R., Gao, Y. T., Yang, G., Li, H. L., Elasy, T. A., et al. (2008) Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study. Am. J. Clin. Nutr. 87, 162–167
65. Ye, Y. B., Chen, A. L., Lu, W., Zhuo, S. Y., Liu, J., et al. (2015) Daidzein and genistein fail to improve glycemic control and insulin sensitivity in Chinese women with impaired glucose regulation: a double-blind, randomized, placebo-controlled trial. Mol. Nutr. Food Res. 59, 240–249
66. Choquette, S., Riesco, E., Cormier, E., Dion, T., Aubertin-Leheudre, M., et al. (2011) Effects of soya isoflavones and exercise on body composition and clinical risk factors of cardiovascular diseases in overweight postmenopausal women: a 6-month double-blind controlled trial. Br. J. Nutr. 105, 1199–1209
67. Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L. P., Hoehn, K. L., et al. (2007) Lipid mediators of insulin resistance. Nutr. Rev. 65, S39–S46
68. Arner, P. (2003) The adipocyte in insulin resistance: key molecules and the impact of the thiazolidinediones. Trends Endocrinol. Metab. 14, 137–145
69. Ozder, A. (2014) Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis. 13, 183
70. Yoko Takahashi, T. I. (2007) Alteration by dietary soy isoflavone of SERBP-1-dependent genes in the liver of rats fed a high saturated-fat diet. Rep. Nat'l. Food Res. Inst. 71, 7–13
71. Shoelson, S. E., Lee, J., and Goldfine, A. B. (2006) Inflammation and insulin resistance. J. Clin. Invest. 116, 1793–1801
72. Wellen, K. E., and Hotamisligil, G. S. (2003) Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785–1788
73. Leon, B. M., and Maddox, T. M. (2015) Diabetes and cardiovascular disease: epidemiology, biological mechanisms, treatment recommendations and future research. World J. Diabetes. 6, 1246–1258
74. Hotamisligil, G. S., Shargill, N. S., and Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science. 259, 87–91
75. Sakamoto, Y., Naka, A., Ohara, N., Kondo, K., and Iida, K. (2014) Daidzein regulates proinflammatory adipokines thereby improving obesity-related inflammation through PPARgamma. Mol. Nutr. Food Res. 58, 718–726